(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.10%) $82.55
(0.99%) $2.05
(-0.51%) $2 345.70
(-1.14%) $27.35
(-0.31%) $958.50
(-0.18%) $0.933
(-0.28%) $10.99
(-0.53%) $0.796
(1.56%) $93.31
2.60% $ 94.04
@ $93.99
Ausgestellt: 29 Apr 2024 @ 20:32
Rendite: 0.05%
Vorheriges Signal: Apr 29 - 15:35
Vorheriges Signal:
Rendite: 1.39 %
Live Chart Being Loaded With Signals
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle...
Stats | |
---|---|
Tagesvolumen | 1.30M |
Durchschnittsvolumen | 1.39M |
Marktkapitalisierung | 11.21B |
EPS | $0 ( 2024-02-28 ) |
Nächstes Ertragsdatum | ( $-0.710 ) 2024-05-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -21.04 |
ATR14 | $4.00 (4.26%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-25 | Sheena Jonathan | Sell | 500 | Common Stock |
2024-04-24 | Brophy Michael Burkes | Sell | 937 | Common Stock |
2024-04-25 | Brophy Michael Burkes | Sell | 705 | Common Stock |
2024-04-26 | Brophy Michael Burkes | Sell | 751 | Common Stock |
2024-04-21 | Sheena Jonathan | Buy | 143 | Common Stock |
INSIDER POWER |
---|
-59.97 |
Last 100 transactions |
Buy: 170 631 | Sell: 679 717 |
Volumen Korrelation
Natera Inc Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Natera Inc Korrelation - Währung/Rohstoff
Natera Inc Finanzdaten
Annual | 2023 |
Umsatz: | $1.08B |
Bruttogewinn: | $492.74M (45.52 %) |
EPS: | $-3.78 |
FY | 2023 |
Umsatz: | $1.08B |
Bruttogewinn: | $492.74M (45.52 %) |
EPS: | $-3.78 |
FY | 2022 |
Umsatz: | $820.22M |
Bruttogewinn: | $363.97M (44.37 %) |
EPS: | $-5.57 |
FY | 2021 |
Umsatz: | $625.49M |
Bruttogewinn: | $307.07M (49.09 %) |
EPS: | $-5.21 |
Financial Reports:
No articles found.
Natera Inc
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is based in Austin, Texas.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.